Search Results - "Gibb, Fraser W."

UK's Association of British Clinical Diabetologist's Diabetes Technology Network (ABCD‐DTN): Best practice guide for hybrid closed‐loop therapy by Griffin, Tomás P., Gallen, Geraldine, Hartnell, Sara, Crabtree, Thomas, Holloway, Melissa, Gibb, Fraser W., Lumb, Alistair, Wilmot, Emma G., Choudhary, Pratik, Hussain, Sufyan

“…This best practice guide is written with the aim of providing an overview of current hybrid closed‐loop (HCL) systems in use within the United Kingdom's (UK)…”
Get full text

Predicting outcomes and complications following radioiodine therapy in Graves’ thyrotoxicosis by Aung, Ei Thuzar, Zammitt, Nicola N., Dover, Anna R., Strachan, Mark W. J., Seckl, Jonathan R., Gibb, Fraser W.

“…Summary Objective Radioiodine (RAI) is an effective treatment for Graves’ thyrotoxicosis but is associated with a failure rate of 15% and may be a risk factor…”
Get full text

COVID-19 vaccine-associated subacute thyroiditis: an unusual suspect for de Quervain’s thyroiditis by Jeeyavudeen, Mohammad Sadiq, Patrick, Alan W, Gibb, Fraser W, Dover, Anna R

“…Subacute thyroiditis following vaccination is an uncommon presentation of thyrotoxicosis. As the world undertakes its largest immunisation campaign to date in…”
Get full text

Thyrotropin Receptor Antibody Levels at Diagnosis and After Thionamide Course Predict Graves' Disease Relapse by Tun, Nyo Nyo Z, Beckett, Geoff, Zammitt, Nicola N, Strachan, Mark W J, Seckl, Jonathan R, Gibb, Fraser W

“…Thionamides are associated with a high risk of recurrence following cessation. Thyrotropin receptor-stimulating antibody (TRAb) levels at diagnosis and/or…”
Get more information

Risk of death following admission to a UK hospital with diabetic ketoacidosis by Gibb, Fraser W., Teoh, Wei Leng, Graham, Joanne, Lockman, K. Ann

“…Aims/hypothesis The aim of this study was to assess the risk of death during hospital admission for diabetic ketoacidosis (DKA) and, subsequently, following…”
Get full text

Marked improvement in HbA1c following commencement of flash glucose monitoring in people with type 1 diabetes by Tyndall, Victoria, Stimson, Roland H., Zammitt, Nicola N., Ritchie, Stuart A., McKnight, John A., Dover, Anna R., Gibb, Fraser W.

“…Aims/hypothesis Minimal evidence supports the efficacy of flash monitoring in lowering HbA 1c . We sought to assess the impact of introducing flash monitoring…”
Get full text

HbA1c reduction following flash monitoring commencement is not independently associated with adverse diabetic eye disease outcomes in type 1 diabetes by Al-Dalla Ali, Muhammad, Stimson, Roland H, Dover, Anna R, Forbes, Shareen, Annoh, Roxanne, Madill, Karen, Gibb, Fraser W

“…IntroductionIntensification of therapy has been associated with early worsening of retinopathy prior to subsequent risk reduction. We sought to assess whether…”
Get full text

Presentation, diagnostic assessment and surgical outcomes in primary hyperparathyroidism: a single centre’s experience by Reid, Laura J, Muthukrishnan, Bala, Patel, Dilip, Crane, Mike S, Akyol, Murat, Thomson, Andrew, Seckl, Jonathan R, Gibb, Fraser W

“…Objective Primary hyperparathyroidism (PHPT) is a common reason for referral to endocrinology but the evidence base guiding assessment is limited. We evaluated…”
Get full text

575-P: Improvement in HbA1c after Flash Monitoring Is Not Associated with Risk of Retinopathy Progression in Type 1 Diabetes by LINTON, KATHRYN, GIBB, FRASER W.

“…Background: Rapid improvement in HbA1c has been associated with significant short-term worsening of diabetic retinopathy. Flash monitoring (FM) is associated…”
Get full text

Low plasma glucose results in non-diabetic adults referred from primary care are not associated with morbidity, mortality, or underlying endogenous hypoglycemic disorders by Linton, Kathryn, Seckl, Jonathan R., Gibb, Fraser W.

Get full text

Preserved C-peptide secretion is associated with fewer low-glucose events and lower glucose variability on flash glucose monitoring in adults with type 1 diabetes by Gibb, Fraser W., McKnight, John A., Clarke, Catriona, Strachan, Mark W. J.

“…Aims/hypothesis We aimed to assess whether persistence of C-peptide secretion is associated with less glucose variability and fewer low-glucose events in…”
Get full text

ENDOCRINOLOGY IN THE TIME OF COVID-19: Remodelling diabetes services and emerging innovation by Wake, Deborah J, Gibb, Fraser W, Kar, Partha, Kennon, Brian, Klonoff, David C, Rayman, Gerry, Rutter, Martin K, Sainsbury, Chris, Semple, Robert K

“…The COVID-19 pandemic is a major international emergency leading to unprecedented medical, economic and societal challenges. Countries around the globe are…”
Get full text

Predictors of Nephrolithiasis, Osteoporosis, and Mortality in Primary Hyperparathyroidism by Reid, Laura J, Muthukrishnan, Bala, Patel, Dilip, Seckl, Jonathan R, Gibb, Fraser W

“…Abstract Context Primary hyperparathyroidism (PHPT) has a prevalence of 0.86% and is associated with increased risk of nephrolithiasis and osteoporosis. PHPT…”
Get full text

249-OR: Predictors of Impaired Awareness of Hypoglycemia in Adults with Type 1 Diabetes by GIBB, FRASER W., STIMSON, ROLAND H., FORBES, SHAREEN, DOVER, ANNA R.

“…Background: Impaired awareness of hypoglycemia (IAH) is associated with a substantially increased risk of severe hypoglycemia (SH) in type 1 diabetes. Risk…”
Get full text

Flash Glucose Monitoring Improves Outcomes in a Type 1 Diabetes Clinic by Dover, Anna R., Stimson, Roland H., Zammitt, Nicola N., Gibb, Fraser W.

Get full text

Outcomes after 1 year in adults using Omnipod 5: Real‐world data from a UK diabetes centre by Stimson, Roland H., Strachan, Mark W. J., Dover, Anna R., Wright, Rohana J., Forbes, Shareen, McRobert, Gayle, Gibb, Fraser W.

Get full text

Efficacy and safety of cotadutide, a dual glucagon‐like peptide‐1 and glucagon receptor agonist, in a randomized phase 2a study of patients with type 2 diabetes and chronic kidney disease by Parker, Victoria E. R., Hoang, Thuong, Schlichthaar, Heike, Gibb, Fraser W., Wenzel, Barbara, Posch, Maximillian G., Rose, Ludger, Chang, Yi‐Ting, Petrone, Marcella, Hansen, Lars, Ambery, Philip, Jermutus, Lutz, Heerspink, Hiddo J. L., McCrimmon, Rory J.

“…Aim To assess the efficacy, safety and tolerability of cotadutide in patients with type 2 diabetes mellitus and chronic kidney disease. Materials and Methods…”
Get full text

Changes in continuous glucose monitoring metrics and predictors of improvement 12 months after conversion from Freestyle Libre to Freestyle Libre 2 by Stimson, Roland H, Dover, Anna R, Strachan, Mark W J, Wright, Rohana J, Forbes, Shareen, Gibb, Fraser W

“…We sought to assess whether conversion from Freestyle Libre to Freestyle Libre 2 (with low and high glucose alert functions) was associated with improved…”
Get full text

Impact of routine clinic measurement of serum C‐peptide in people with a clinician‐diagnosis of type 1 diabetes by Foteinopoulou, Evgenia, Clarke, Catriona A. L., Pattenden, Rebecca J., Ritchie, Stuart A., McMurray, Emily M., Reynolds, Rebecca M., Arunagirinathan, Ganesan, Gibb, Fraser W., McKnight, John A., Strachan, Mark W. J.

“…ABSTRACT Aims/hypothesis The aim of this study was to determine the impact of the routine use of serum C‐peptide in an out‐patient clinic setting on…”
Get full text

Higher Insulin Resistance and Adiposity in Postmenopausal Women With Breast Cancer Treated With Aromatase Inhibitors by Gibb, Fraser W, Dixon, J Michael, Clarke, Catriona, Homer, Natalie Z, Faqehi, Abdullah M M, Andrew, Ruth, Walker, Brian R

“…Abstract Context Aromatase deficiency causes obesity and insulin resistance in aromatase knockout mice and humans with rare mutations of the aromatase gene…”
Get full text